title: Lithium clearance: modification by the loop of Henle in man.
abstract: 1. The contribution of Li+ reabsorption in the loop of Henle to lithium clearance (CLi) and the possible mechanism(s) involved were assessed in healthy volunteers. Four mechanisms were considered: (a) passive reabsorption in the thin ascending limb, (b) solvent drag in the thin descending limb, (c) the Na+, K+, 2Cl- transporter in the thick ascending limb and (d) paracellular movement in the thick ascending limb. 2. Since alterations in the corticomedullary osmolal concentration gradient produced by fluid restriction (500 ml day-1) and subsequent water loading (15 ml kg-1) did not affect either CLi (28.5 +/- 2.1 vs. 28.2 +/- 1.9 ml min-1) or fractional lithium clearance (FELi; 23.5 +/- 2.0 vs. 23.0 +/- 1.9%), it is unlikely that substantial Li+ reabsorption occurs in the thin limbs by either passive movement or solvent drag. 3. Increasing plasma Li+ with unchanged plasma Na+ in salt-replete volunteers was associated with only small reductions in CLi (32.8 +/- 1.3 ml min-1, P less than 0.05) and FELi (27.3 +/- 1.8 vs. 25.3 +/- 2.0%, P less than 0.05). This suggests that substantial Li+ reabsorption on the Na+, K+, 2Cl- transporter does not occur. 4. Bumetanide increased FELi in salt-depleted (LS) and salt-replete (HS) volunteers and abolished the pre-diuretic difference in FELi between salt intakes (LS, 16.6 +/- 1.5 vs. 38.7 +/- 2.3%, P less than 0.001; HS, 30.1 +/- 1.5 vs. 40.5 +/- 2.0%, P less than 0.001). Changes in CPO4 and CHCO3 were not detected. Acetazolamide produced comparable increases in FELi (LS, 16.6 +/- 1.5 vs. 38.7 +/- 2.2%, P less than 0.001; HS, 30.1 +/- 1.5 vs. 43.1 +/- 2.4%, P less than 0.01); and CPO4 and CHCO3 were increased. When tubular flow to the loop of Henle was increased by acetazolamide, the bumetanide-induced increases in FELi were reduced (LS, 38.7 +/- 2.2 vs. 48.7 +/- 2.3%, P less than 0.001; HS, 43.1 +/- 2.4 vs. 48.1 +/- 2.6%, P less than 0.001). 5. These data are consistent with the view that (a) Li+ is reabsorbed by a bumetanide-sensitive mechanism in the loop of Henle, (b) approximately 20 and 10% of the filtered load, respectively, is reabsorbed in the loop in salt-depleted and salt-replete volunteers, (c) flow-dependent, voltage-driven paracellular movement in the thick ascending limb is the likely mechanism and (d) this mechanism could account for the difference in Li+ reabsorption between low and high salt intakes.
authors.affiliation: Department of Physiological Sciences, Manchester University.
authors.forename: J C
authors.initials: JC
authors.lastname: Atherton
authors.forename: A
authors.initials: A
authors.lastname: Doyle
authors.forename: A
authors.initials: A
authors.lastname: Gee
authors.forename: R
authors.initials: R
authors.lastname: Green
authors.forename: S
authors.initials: S
authors.lastname: Gingell
authors.forename: F
authors.initials: F
authors.lastname: Nicholls
authors.forename: L
authors.initials: L
authors.lastname: Pempkowiak
authors.forename: J
authors.initials: J
authors.lastname: Plange-Rhule
mesh_terms: D000042:Absorption / Q000187:drug effects; D000086:Acetazolamide / Q000494:pharmacology; D002034:Bumetanide / Q000494:pharmacology; D005260:Female; D006801:Humans; D008094:Lithium / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D008138:Loop of Henle / Q000378:metabolism*; D008297:Male; D012982:Sodium, Dietary / Q000008:administration & dosage; D014882:Water-Electrolyte Balance / Q000502:physiology
chemical_list: D012982:Sodium, Dietary; D002034:Bumetanide; D008094:Lithium; D000086:Acetazolamide